Journals / Türkiye Parazitoloji Dergisi / 2002 / Cilt: 26 - Sayı: 4

Albendazole ve mebendazole'ün E. grnulosis'un minyatür kistleri üzerindeki in vitro etkisinin araştırılması

In vitro efficacies of albendazole and mebendazole against miniature cysts of Echinococcus granulosus

Pages
396–399
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result of this study, the miniature hydatid cysts can be used as an in vitro model for drug investigations and experimental studies in the future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Human cystic echinococcosis (CE) is a zoonotic infection caused by larval forms (metacestodes) of Echinococcus granulosus.
📊
Key Findings & Data:There was no statistically significant difference between the 2 drugs when a low dose was given on the 7th day but albendazole was found to be more effective on the 15th and 30th days.
💡
Conclusion & Impact:As a result of this study, the miniature hydatid cysts can be used as an in vitro model for drug investigations and experimental studies in the future.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Human cystic echinococcosis (CE) is a zoonotic infection caused by larval forms (metacestodes) of Echinococcus granulosus. CE is still an important public health and economic problem in many parts of the world including Turkey. Surgical intervention is still the treatment of choice for CE. In recent years, the chemotherapeutic treatment of hydatid disease in man, as supplementary or alternative to surgery, has been widely studied using the benzimidazole derivates albendazole and mebendazole. In this study, miniature hydatid cysts from Echinococcus granulosus protoscolices have been developed and in vitro efficacies of albendazole and mebendazole against them were investigated. Both drugs were found to be comparatively effective on miniature hydatid cysts. There was no statistically significant difference between the 2 drugs when a low dose was given on the 7th day but albendazole was found to be more effective on the 15th and 30th days. As a result of this study, the miniature hydatid cysts can be used as an in vitro model for drug investigations and experimental studies in the future.

Özet

Kistik ekinokokkozis (CE), Echinococcus granulosus'un larval formunun sebep olduğu zoonotik bir enfeksiyondur. Türkiye'nin de dahil olduğu dünyanın pek çok bölgesinde halen önemli bir halk sağlığı ve ekonomik problem olarak karşımıza çıkmaktadır. Günümüzde cerrahi girişim CE tedavisinde halen geçerli olan tedavidir. Ancak Benzimidazole türevlerinden Albendazole ve Mebendazole'ün, son yıllarda hidatik kist tedavisinde cerrahiye yardımcı veya alternatif olarak kullanımı ile ilgili çalışmalar yapılmaktadır. Bu çalışmada, E. granulosus protoskolekslerinden in vitro besiyeri ortamında 3 ayda minyatür hidatik kistler geliştirilmiş ve bu kistler üzerinde Albendazole ve Mebendazole'ün in vitro etkileri araştırılmıştır. Her iki ilacın da minyatür hidatik kistler üzerinde etkinlik gösterdiği, Albendazole ile Mebandazole karşılaştırıldığında ise; sadece düşük dozda 7'inci günde fark bulunamazken, 15'inci ve 30'uncu günlerde Albendazole'ün daha etkili olduğu gözlenmiştir. Minyatür hidatik kistlerin ilaç araştırmaları ve deneysel çalışmalarda kullanılabilecek in vitro bir model olabileceği sonucuna varılmıştır.

🔖

Cite This Article

ERTABAKLAR, H., ALTINTAŞ, N. (2022). Albendazole ve mebendazole'ün E. grnulosis'un minyatür kistleri üzerindeki in vitro etkisinin araştırılması. Türkiye Parazitoloji Dergisi, Cilt: 26 - Sayı: 4, 396–399. https://ajindex.com/articles/631009

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Casado N, Perez-Serrano-J, Denegri G, Rodriguez-Caabeiro F, 1996. Development of chemothrapeutic model for the in vitro screening of drugs against Kgranulosus cysts: the effect of an Albendazole-Albendazole sulfoxide combination. Int J Parasitol, 26(1): 59-65
  2. Erdinçler P, Kaynar MY, Babuna O, Canbaz B, 1997. The role of mebandazole in the surgical treatment of central nervous system hydatid disease. Br J Neurosurg, 11(2): 116-120
  3. Franchi C, Di Vico B, Teggi A, 1999. Long-term evaluation of patients with hydatidosis treated with Benzimidazole carbamates. Cilin Infect Dis, 29: 304-309
  4. Horton RJ, 1997. Albendazole in treatment of human cystic echinococcosis: 12 years experience. Açta Trop, 64: 79-81
  5. Lasey E, 1990. Mode of action of Benzimidazoles. Parasitology y, 6(4): 112-115
  6. Morris DL, Dykes PW, Marriner S, Boğan J, 1985. Albendazole-objective evidence of response in human hydatid disease. JAMA, 253(14): 2-5
  7. Perez-Serrano J, Casado N, Rodriguez-Caabeiro F, 1994. The effects of Albendazole and Albendazole sulfoxide combination-therapy on Echinococcus granulosus in vitro. Int J Parasitol, 24(2): 219-224
  8. Salmot AG, Meulemans A, Cremieux AC, Giovanangeli MD, Hay JM, Delaıtre B, 1983. Albendazole as a potential treatment for human hydatidosis. The Lancet, 17: 652-656
  9. Teggi A, Lastilla GM, De Rosa F. 1993. Therapy of human hydatid diseasewith Mebendazole and Albendazole. Antimicrob Agent Chemother, 37(8); 1679-1684
  10. Vuitton DA, 1999. New trends in the treatment of echinococcosis. Helmintologia, 36 (3):167-170
  11. WHO informal working group on echinococcosis, 1996. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bulletin WHO, 74(3): 231-242.